Social Media in the Pharmaceutical Industry
White Paper Jan 24, 2012
Two primary themes are captured in the paper:
1. Social media is a fundamental part of advancing public health.
2. Pharmaceutical companies have a responsibility to engage more fully in social media.
The paper includes the thoughts of patients, health advocates, former government officials, bloggers and others who participated in a roundtable discussion that AstraZeneca convened late last year. The discussion, which was facilitated by members of Google’s Health Industry Team, sought specific feedback on AstraZeneca’s social media principles – and included considerable discussion on the social media guidelines expected to be released by the FDA later this year.
It summarises and addresses key discussion points that arose from both the Social Media Roundtable and DPE, as well as several considerations for the FDA in its development of social media guidance.
In the paper, Astrazeneca put forth five principles required for appropriate pharmaceutical manufacturer engagement in social media.
The white paper says the FDA should engage with the pharmaceutical industry to help them research and resolve issues raised by social media.
Related White Papers
Big Data Lipidomics for Lipid Biomarker Identification and Drug DiscoveryWhite Paper
Data analysis process aiming at the identification of lipid biomarkers and the
evaluations of their performance.
Biophysical Application of Calorimetric Methods to Protein Misfolding and Aggregation ExaminationsWhite Paper
Promoting calorimetry-based studies on protein misfolding by developing treatments and prevention of aggregation-related diseases.READ MORE
Asthma- and COPD-related Differential Gene Expression in Primary Human Lung FibroblastsWhite Paper
This white paper summarizes a study comparing normal versus COPD lung fibroblasts and normal versus asthma lung fibroblasts to explore differences in gene expression among the donor samples.READ MORE
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018